Article Authors and Podcast Contributors
Article Authors
Transvenous Extraction of Conduction System Pacing Leads: An International Multicenter (TECSPAM) study
Pugazhendhi Vijayaraman, MD, Rohan S. Trivedi, MD, Jayanthi N. Koneru, MD, Parikshit S. Sharma, MD, MPH, Jan De Pooter, MD, PhD, Robert D. Schaller, MD, Óscar Cano, MD6, Zachary I. Whinnett, MD, Federico Migliore, MD, Shunmuga Sundaram Ponnusamy, MD, Jamario R. Skeete, MD, Francesco Zanon, MD, Frederic V. Heuverswyn, MD, Jeffrey Kolominsky, MD, Raimondo Pittorru, MD, Mishal Mumtaz, MD, Kenneth A. Ellenbogen, MD, Bengt Herweg, MD
Safety, Efficacy, and Reliability Evaluation of a Novel Small-Diameter Defibrillation Lead: Global LEADR Pivotal Trial Results
George H. Crossley, MD; Prashanthan Sanders, MBBS, PhD; Bert Hansky, MD; Paolo De Filippo, MD; Maully J. Shah, MD; Morjo Shoda, MD, PhD; Surinder Kaur Khelae, MDg; Travis Richardson, MD; Francois Philippon, MD; John S. Zakaib, MD; Hung-Fat Tse, MD, PhD; Darius P. Sholevar, MD; Christopher Stellbrink, MD; Rajeev K. Pathak, MBBS, PhDm; Goran Milasinovic, MD; Jason S. Chinitz, MDo; Bernice Tsang, MD; Michael B. West, MDq; Brian M. Ramza, MDr; Xuebin Han, MD; Babak Bozorgnia, MD; Roberto Carta, PhDu; Tessa Geelen, PhD; Adam Himes, MS; Megan Platneru; Amy E. Thompson, MS; Pamela Mason, MDw, for the Lead EvaluAtion for Defibrillation and Rliability Trial Investigators
Tachycardia therapy and Endpoint Results of the First Modular, Intra-body, Communicating Subcutaneous Defibrillator-Leadless Pacemaker System: MODULAR ATP Interim Cohort
Dr. Reinoud Knops, Dr. Vivek Y. Reddy, Paul Roberts, Mr. David L. Wright, Dr. Lucas V. A. Boersma, Dr. Rahul N Doshi, Dr. Paul A. Friedman, Prof. Petr Neuzil, Dr. Carina Blomström-Lundqvist, Dr. Maria Grazia Bongiorni, Dr. Martin C. Burke, Dr. Daniel Gras, Dr. Steven P. Kutalek, Dr. Anish K. Amin, Dr. Eugene Y. Fu, Dr. Laurence M. Epstein, Dr. Jose M. Tolosana, Dr. Thomas D. Callahan, Dr. Johan D. Aasbo, Dr. Ralph Sayre Augostini, Dr. Harish Manyam, Dr. Devi G. Nair, Dr. Blandine A. Mondesert, Dr. Wilber W. Su, Dr. Chris Pepper, Dr. Marc A Miller, Dr. Jon A. Grammes, Karim Saleh, Dr. christelle marquie, Dr. Faisal M. Merchant, Dr. Yong-Mei Cha, Dr. Colin Cunnington, Dr. David S. Frankel, Ms. Julie West, Ms. Elizabeth Matznick, Benjamin Speakman, Amy Brisben, Dr. Jonathan Weinstock, Kenneth M. Stein, Dr. Lluis Mont, Dr. Michael S. Lloyd
Podcast Hosts
Deepthy Varghese, MSN, ACNP, FNP
Christopher Cheung, MD, MPHDanesh Kella, MBBS
Podcast Participants
Christopher Aldo A. Rinaldi, MBBS, MD, FHRS
Miguel A. Leal, MD, FHRS
Rajeev Kumar Pathak, MBBS, PhD, FHRS
Mihail G. Chelu, MD, PhD, FHRS
Anish K. Amin, MD, FHRS
Emily P. Zeitler, MD, MHS, FHRS
ACE Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.
Host Disclosure(s):
C. Cheung: Research: Abbott, Speaking/Teaching: Biosense Webster, Abbott, Biotronik
D. Kella: Speakering, Teaching, and Consulting: Zoll Medical Corporation
D. Varghese: Nothing to disclose
Contributor Disclosure(s):
C. Rinaldi: Research: Abbott, Medtronic, Boston Scientific, LivaNova, Membership on Advisory Committees: EBR Systems, Speaking and Teaching: Spectranetics Corporation
M. Leal: Speaking and Teaching: Sanofi, Research: Medtronic
R. Pathak: Nothing to disclose.
M. Chelu: Research: Impulse Dynamics USA, Abbott, PCORI, NIH/NHLBI, Speaking and Teaching: Impulse Synamics USA
A. Amin: Speaking, Teaching, and Consulting: Medtronic, Boston Scientific, Philips
E. Zeitler: Research: Sanofi, Bionsense Webster, Inc., Speaking, Teaching, and Consulting: Biosense Webster, Inc., Boston Scientific, Element Science, Inc., Membership on Advisory Committees: Medtronic
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.